Kimberly-Clark/$KMB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kimberly-Clark
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Ticker
$KMB
Sector
Primary listing
Industry
Household Products
Headquarters
Employees
38,000
ISIN
US4943681035
Website
Kimberly-Clark Metrics
BasicAdvanced
$42B
17.37
$7.34
0.39
$4.96
3.95%
Price and volume
Market cap
$42B
Beta
0.39
52-week high
$150.45
52-week low
$124.10
Average daily volume
2.4M
Dividend rate
$4.96
Financial strength
Current ratio
0.763
Quick ratio
0.396
Long term debt to equity
532.516
Total debt to equity
595.098
Dividend payout ratio (TTM)
66.33%
Interest coverage (TTM)
11.81%
Profitability
EBITDA (TTM)
3,860
Gross margin (TTM)
36.45%
Net profit margin (TTM)
12.48%
Operating margin (TTM)
15.96%
Effective tax rate (TTM)
17.97%
Revenue per employee (TTM)
$520,000
Management effectiveness
Return on assets (TTM)
11.54%
Return on equity (TTM)
207.06%
Valuation
Price to earnings (TTM)
17.372
Price to revenue (TTM)
2.159
Price to book
38.44
Price to tangible book (TTM)
-44.32
Price to free cash flow (TTM)
17.824
Free cash flow yield (TTM)
5.61%
Free cash flow per share (TTM)
715.51%
Dividend yield (TTM)
3.89%
Forward dividend yield
3.95%
Growth
Revenue change (TTM)
-3.12%
Earnings per share change (TTM)
34.72%
3-year revenue growth (CAGR)
-0.07%
10-year revenue growth (CAGR)
0.11%
3-year earnings per share growth (CAGR)
12.33%
10-year earnings per share growth (CAGR)
6.55%
3-year dividend per share growth (CAGR)
2.42%
10-year dividend per share growth (CAGR)
3.76%
What the Analysts think about Kimberly-Clark
Analyst ratings (Buy, Hold, Sell) for Kimberly-Clark stock.
Bulls say / Bears say
Kimberly-Clark's strategic focus on the growing adult incontinence market, with brands like Depend and Plenitud, positions the company to capitalize on demographic trends and a market projected to reach $20 billion by 2029. (ft.com)
The planned $3.5 billion sale of its international tissue business to Suzano allows Kimberly-Clark to streamline operations and focus on core, higher-margin segments, potentially enhancing profitability. (reuters.com)
Despite challenges, Kimberly-Clark reported a 1% organic sales growth in Q3 2024, driven by strong in-market execution and effective cost management, indicating resilience and operational efficiency. (kimberly-clark.com)
Kimberly-Clark lowered its 2025 profit forecast due to approximately $300 million in additional costs from new U.S. trade tariffs, highlighting vulnerability to geopolitical factors. (reuters.com)
In Q1 2025, the company reported a 6% decline in net sales to $4.84 billion and a 12.4% drop in net income, reflecting challenges in maintaining revenue and profitability. (industryintel.com)
The divestiture of its international tissue business, while streamlining operations, may reduce global market presence and expose the company to risks associated with over-reliance on specific segments. (ft.com)
Data summarised monthly by Lightyear AI. Last updated on 29 Jun 2025.
Kimberly-Clark Financial Performance
Revenues and expenses
Kimberly-Clark Earnings Performance
Company profitability
Kimberly-Clark News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kimberly-Clark stock?
Kimberly-Clark (KMB) has a market cap of $42B as of July 21, 2025.
What is the P/E ratio for Kimberly-Clark stock?
The price to earnings (P/E) ratio for Kimberly-Clark (KMB) stock is 17.37 as of July 21, 2025.
Does Kimberly-Clark stock pay dividends?
Yes, the Kimberly-Clark (KMB) stock pays dividends to shareholders. As of July 21, 2025, the dividend rate is $4.96 and the yield is 3.95%. Kimberly-Clark has a payout ratio of 66.33% on a trailing twelve-month basis.
When is the next Kimberly-Clark dividend payment date?
The next Kimberly-Clark (KMB) dividend payment date is unconfirmed.
What is the beta indicator for Kimberly-Clark?
Kimberly-Clark (KMB) has a beta rating of 0.39. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.